Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Sattler

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|August 29, 1983
Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infectionsF R Sattler, S Hall, C E Hanna, et al.
Digestive Diseases and Sciences|December 1, 1991
Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitisB A Runyon, E A Akriviadis, F R Sattler, et al.
Chest|June 1, 1978
Miconazole for treatment of disseminated coccidioidomycosis. Unfavorable experienceR D Meyer, F R Sattler, S R Linné, et al.
American Journal of Surgery|May 31, 1988
Impaired hemostasis caused by beta-lactam antibioticsF R Sattler, M R Weitekamp, A Sayegh, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1982
A human hepatoma cell line (PCL/PRF/5) produces lung metastases and secretes HBsAg in nude miceF R Sattler, S Paolucci, J W Kreider, et al.
The American Journal of Medicine|August 1, 1986
Cefoperazone for empiric therapy in patients with impaired renal functionF R Sattler, D J Colao, G M Caputo, et al.
Annals of Internal Medicine|March 1, 1983
Penicillin-resistant pneumococcus and meningitisG M Caputo, F R Sattler, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1986
Reduction of oral flora with rifampin in healthy volunteersP C Appelbaum, S K Spangler, C R Potter, et al.
Therapeutic Drug Monitoring|August 1, 1997
A population pharmacokinetic model of trimethoprim in patients with pneumocystis pneumonia, made with parametric and nonparametric methodsR W Jelliffe, P Gomis, B Tahani, et al.
JAMA|July 15, 1988
Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumoniaH Waskin, J K Stehr-Green, C G Helmick, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|August 29, 1983
Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infectionsF R Sattler, S Hall, C E Hanna, et al.
Digestive Diseases and Sciences|December 1, 1991
Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitisB A Runyon, E A Akriviadis, F R Sattler, et al.
Chest|June 1, 1978
Miconazole for treatment of disseminated coccidioidomycosis. Unfavorable experienceR D Meyer, F R Sattler, S R Linné, et al.
American Journal of Surgery|May 31, 1988
Impaired hemostasis caused by beta-lactam antibioticsF R Sattler, M R Weitekamp, A Sayegh, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1982
A human hepatoma cell line (PCL/PRF/5) produces lung metastases and secretes HBsAg in nude miceF R Sattler, S Paolucci, J W Kreider, et al.
The American Journal of Medicine|August 1, 1986
Cefoperazone for empiric therapy in patients with impaired renal functionF R Sattler, D J Colao, G M Caputo, et al.
Annals of Internal Medicine|March 1, 1983
Penicillin-resistant pneumococcus and meningitisG M Caputo, F R Sattler, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1986
Reduction of oral flora with rifampin in healthy volunteersP C Appelbaum, S K Spangler, C R Potter, et al.
Therapeutic Drug Monitoring|August 1, 1997
A population pharmacokinetic model of trimethoprim in patients with pneumocystis pneumonia, made with parametric and nonparametric methodsR W Jelliffe, P Gomis, B Tahani, et al.
JAMA|July 15, 1988
Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumoniaH Waskin, J K Stehr-Green, C G Helmick, et al.
Pageof 7